.png?1776088361)
Series A · Boston
Biotech
Precision autoimmune therapies
beelinemedicines.com (opens in a new tab)$126.3MSeries A ext.Jun 2026
Led by Bain Capital
Recent raises4 open roles
.png?1776088361)
Beeline MedicinesOn-site · US
.png?1776088361)
Beeline MedicinesOn-site · Boston
.png?1776088361)
Beeline MedicinesOn-site · US
.png?1776088361)
Beeline MedicinesOn-site · US